Abeona Therapeutics Inc (ABEO)
EBITDA Margin
-163.99%
Quarterly · Period ending:
ABEO EBITDA Margin
Latest reported-163.99%period ending
Latest reported-163.99%period ending
ABEO Quarterly EBITDA Margin (-300.00% → -163.99%)
Quarterly ebitda margin
High-resolution chart · PNG
ABEO ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -163.9895% | |
| -176.3073% | |
| -345% | |
| 0% | |
| 31,517.5% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -448.9429% | |
| 0% | |
| -16,142.6471% | |
| 0% | |
| -809.8% | |
| -3,846.8208% | |
| -433% | |
| 0% | |
| 0% | |
| 0% | |
| -453.3333% | |
| -68.6714% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 878.5714% | |
| -931.0123% | |
| -4,329.7101% | |
| -1,949.7175% | |
| -3,861.8605% | |
| -2,375.7991% | |
| -3,718.4332% | |
| -2,685.4839% | |
| -2,637.5% | |
| -1,304.8913% | |
| -3,047.1963% | |
| -2,284.2553% | |
| -1,017.6744% | |
| -2,077.5439% | |
| -1,410.9929% | |
| -729.0698% | |
| -195.7265% | |
| -559.7458% | |
| -5,007.6923% | |
| -353.9663% | |
| -603.0864% | |
| -31.746% | |
| 565.9529% | |
| 337.0098% | |
| -646.0239% | |
| -1,683.4673% | |
| -1,508.9855% | |
| -251.6981% | |
| 927.0751% | |
| -165.9942% | |
| -1,452.9801% | |
| -1,392% | |
| -1,237.415% | |
| -1,761.4173% | |
| -1,791.4286% | |
| -1,550.9804% | |
| -1,560.5769% | |
| -2,690.9722% | |
| -3,215.873% | |
| -4,617.0732% | |
| -1,650% | |
| -7,993.617% | |
| -1,583.3333% | |
| -27,621.0526% | |
| -3,613.7255% | |
| -26,500% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 293.7598% | |
| -358.2278% | |
| -879.5181% | |
| -690.9677% | |
| -815.942% | |
| -1,071.8919% | |
| -2,851.4706% | |
| -9,145% | |
| -1,028.3654% | |
| -15,600% | |
| -216.2518% | |
| -504.5802% | |
| -285.5244% | |
| -2,723.0769% | |
| -742.2053% | |
| -1,423.2759% | |
| -12,400% | |
| -15,409.0909% |